Product Information
EFAVIRENZ 600 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.4318 per EA under NDC 31722050430. Its NADAC has been published 393 times since May 16, 2018.
Strength
600 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722050430
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EFAVIRENZApproval Type
Generic (ANDA)
FDA Application
ANDA078886On Market Since
4/27/2018
Pharmacological Classes
Price Statistics
The NADAC for EFAVIRENZ 600 MG TABLET has been published 393 times since May 16, 2018, and over the history we have for it it has declined 94.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4318 per EA |
|---|---|
| All-time high | $27.3463 (Aug 15, 2018) |
| All-time low | $1.3206 (Feb 19, 2025) |
| 52-week high | $1.7446 |
| 52-week low | $1.3661 |
| Median price | $5.4389 |
| Average price | $7.4069 |
| Largest weekly change | -43.3% (Mar 22, 2023) |
| Weeks tracked | 393 |
| Tracking since | May 16, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EFAVIRENZ 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ 600 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.4318 per EA (NDC 31722050430), effective Jun 24, 2026.
How has the price of EFAVIRENZ 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for EFAVIRENZ 600 MG TABLET has declined 94.8%. It has been tracked across 393 weekly CMS publications since May 16, 2018.
What are the highest and lowest recorded NADAC prices for EFAVIRENZ 600 MG TABLET?
Since May 16, 2018, the NADAC for EFAVIRENZ 600 MG TABLET has ranged from a low of $1.3206 (Feb 19, 2025) to a high of $27.3463 (Aug 15, 2018), with a median of $5.4389 per EA.
Are there cheaper alternatives to EFAVIRENZ 600 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as EFAVIRENZ 600 MG TABLET, but none are currently priced below it.
Who manufactures EFAVIRENZ 600 MG TABLET?
EFAVIRENZ 600 MG TABLET (NDC 31722050430) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification